DOXORUBICIN HYDROCHLORIDE
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
68001-704 -
Package NDC
68001-704-26 -
Application number
ANDA212299 -
SPL ID
4dff7ee8-c0a2-c78d-e063-6394a90a79e8 -
SPL set ID
ada390ce-50ea-4de5-be58-5b03caf33c23 -
UNII
82F2G7BL4E -
RxCUI
1790115 -
RxCUI
1790127
What the source publishes
- Labeler
- BluePoint Laboratories
- Active ingredients
- doxorubicin hydrochloride
- Form
- INJECTABLE, LIPOSOMAL
- Routes
- INTRAVENOUS
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "DOXORUBICIN HYDROCHLORIDE",
"splId": "4dff7ee8-c0a2-c78d-e063-6394a90a79e8",
"labels": [
{
"setId": "ada390ce-50ea-4de5-be58-5b03caf33c23",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ada390ce-50ea-4de5-be58-5b03caf33c23",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=ada390ce-50ea-4de5-be58-5b03caf33c23"
}
],
"routes": [
"INTRAVENOUS"
],
"labeler": "BluePoint Laboratories",
"finished": true,
"packaging": [
{
"sample": false,
"description": "1 VIAL, SINGLE-DOSE in 1 CARTON (68001-704-26) / 25 mL in 1 VIAL, SINGLE-DOSE",
"package_ndc": "68001-704-26",
"identifierStatus": "well-formed",
"marketing_start_date": "20260402"
}
],
"productId": "68001-704_4dff7ee8-c0a2-c78d-e063-6394a90a79e8",
"useDomain": "unknown",
"dosageForm": "INJECTABLE, LIPOSOMAL",
"productNdc": "68001-704",
"deaSchedule": null,
"genericName": "doxorubicin hydrochloride",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "DOXORUBICIN HYDROCHLORIDE",
"strength": "2 mg/mL"
}
],
"applicationNumber": "ANDA212299",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20260402",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"unii": [
"82F2G7BL4E"
],
"rxcui": [
"1790115",
"1790127"
],
"spl_set_id": [
"ada390ce-50ea-4de5-be58-5b03caf33c23"
],
"manufacturer_name": [
"BluePoint Laboratories"
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:68001-704_4dff7ee8-c0a2-c78d-e063-6394a90a79e8"